Latest filing published 12 Jun 2024 for Kiromic Biopharma, Inc., €3,100.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael Nagel: trading record in brief
Michael Nagel is a declared insider of Kiromic Biopharma, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 18 March 2024 to 11 June 2024, the count stands at 2 filings.
On the market, this insider has only ever bought: 1 purchase, €3,100 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant.
The latest filing, published on 12 June 2024, reports an open-market purchase of €3,100 in Kiromic Biopharma, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael Nagel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$3.33100.0% of flowCommon StockSEC:0001104659-24-070884:0Canonical exit: 9 Sept 2024 (T+90)
- 18,000 sharesRestricted Stock AwardSEC:0001104659-24-036801:0
2 of 2 declarations